重度抑郁障碍患者背外侧前额叶rTMS治疗反应轨迹:THREE-D研究
该研究为一项随机非劣效试验(N=388)的二次分析,比较传统10-Hz rTMS与间歇性θ爆发刺激(iTBS)治疗难治性重性抑郁障碍,采用基于组的轨迹模型识别HAM-D反应轨迹。共识别出4条轨迹:无反应、快速反应、高基线症状线性反应、低基线症状线性反应;治疗1周内即可检测到轨迹间反应率与缓解率的显著差异。治疗协议与反应轨迹无关联,而基线症状严重程度、年龄、QIDS-SR评分及苯二氮䓬类药物使用与轨迹相关。
要点
- rTMS治疗重性抑郁障碍可识别出4条不同的反应轨迹。
- 治疗1周内即可检测到轨迹间反应率和缓解率的显著差异。
- 治疗协议与反应轨迹无关,基线临床特征与轨迹相关。
核心结论
- 重性抑郁障碍对rTMS表现出不同的反应轨迹,这些轨迹与基线临床特征相关,但与治疗协议无关。
- 不同的rTMS反应轨迹提示可能开发个体化治疗方案。
研究设计与样本
- 随机非劣效试验的二次分析(N=388),比较传统10-Hz rTMS与间歇性θ爆发刺激(iTBS)rTMS。
- 受试者为成人门诊患者,主要诊断为重性抑郁障碍,17项汉密尔顿抑郁量表(HAM-D)评分≥18,且对1至3种足量抗抑郁药试验无反应。
- 治疗为左侧背外侧前额叶rTMS,每周5天,持续4-6周(20-30次),采用基于组的轨迹建模识别HAM-D反应轨迹。
主要发现
- 识别出4条轨迹:无反应(N=43,11%)、快速反应(N=73,19%)、高基线症状线性反应(N=118,30%)、低基线症状线性反应(N=154,40%)。
- 轨迹间反应率和缓解率的显著差异在治疗第1周即可检测到。
- 治疗协议与反应轨迹无关联。
- 较高的基线HAM-D和QIDS-SR评分与无反应轨迹相关。
- 年龄较大、较低QIDS-SR评分及未使用苯二氮䓬类药物与快速反应轨迹相关。
关键数值与推荐
- HAM-D评分≥18为入组标准之一。
- 治疗为每周5天、持续4-6周(20-30次)的rTMS。
- 轨迹分布:无反应11%、快速反应19%、高基线症状线性反应30%、低基线症状线性反应40%。
临床怎么用
- 临床可在rTMS治疗早期(如第1周)评估反应轨迹,以辅助判断后续治疗策略。
- 基线HAM-D和QIDS-SR评分较高者可能提示无反应轨迹风险,需加强监测。
- 年龄较大、QIDS-SR评分较低且未使用苯二氮䓬类药物的患者可能更易出现快速反应。
局限性
- 本研究为二次分析,结果需在前瞻性研究中验证。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for refractory major depressive disorder, yet no studies have characterized trajectories of rTMS response. The aim of this study was to characterize response trajectories for patients with major depression undergoing left dorsolateral prefrontal cortex rTMS and to determine associated baseline clinical characteristics. METHODS: This was a secondary analysis of a randomized noninferiority trial (N=388) comparing conventional 10-Hz rTMS and intermittent theta burst stimulation (iTBS) rTMS. Participants were adult outpatients who had a primary diagnosis of major depressive disorder, had a score ≥18 on the 17-item Hamilton Depression Rating Scale (HAM-D), and did not respond to one to three adequate antidepressant trials. Treatment was either conventional 10-Hz rTMS or iTBS rTMS applied to the dorsolateral prefrontal cortex, 5 days/week over 4-6 weeks (20-30 sessions). Group-based trajectory modeling was applied to identify HAM-D response trajectories, and regression techniques were used to identify associated characteristics. RESULTS: Four trajectories were identified: nonresponse (N=43, 11%); rapid response (N=73, 19%); higher baseline symptoms, linear response (N=118, 30%); and lower baseline symptoms, linear response (N=154, 40%). Significant differences in response and remission rates between trajectories were detectable by week 1. There was no association between treatment protocol and response trajectory. Higher baseline scores on the HAM-D and the Quick Inventory of Depression Symptomatology-Self-Report (QIDS-SR) were associated with the nonresponse trajectory, and older age, lower QIDS-SR score, and lack of benzodiazepine use were associated with the rapid response trajectory. CONCLUSIONS: Major depression shows distinct response trajectories to rTMS, which are associated with baseline clinical characteristics but not treatment protocol. These response trajectories with differential response to rTMS raise the possibility of developing individualized treatment protocols.
引用
- Kaster TS, Downar J, Vila-Rodriguez F, et al. Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study. Am J Psychiatry. 2019. PMID: 30764649. doi:10.1176/appi.ajp.2018.18091096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。